Hepatitis Forums
Hepatitis C Main Forums => Hepatitis C and HIV Coinfection => Topic started by: Hep Editors on April 17, 2017, 10:53:02 am
-
Use of syringe services programs (SSPs), which provide an array of harm reduction services, has risen considerably among injection drug users (IDUs) over the past decade. However, a worrisome proportion of IDUs still share needles with others, putting them at risk of HIV and hepatitis C virus (HCV) transmission.
“Until now, the nation has made substantial progress in preventing HIV among people who inject drugs, but this success is threatened,” said Jonathan Mermin, MD, MPH, director of the CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. “Syringe services programs work, and their expansion is pivotal for progress in the coming decades.”
The Centers for Disease Control and Prevention (CDC) conducted a study of SSP use based on National HIV Behavioral Surveillance interviews of IDUs in 22 U.S. cities with a high HIV prevalence. The report also factored in National HIV Surveillance System data on HIV infection trends.
For more...
https://www.hepmag.com/article/injection-drug-users-increasingly-using-syringe-services-programs